Emphysema & chronic bronchitis    Chronic Obstructive Pulmonary Disease (COPD) is the third most common disease and a leading ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

Dr Sundeep Salvi: Shardul Nautiyal, Mumbai Tuesday, March 4, 2025, 08:00 Hrs [IST] Chronic obstructive pulmonary disease (C ...

Discover why doctors warn against vaping for people with these five health conditions including asthma, heart disease, and ...

The NHS is urging thousands of people to cut down on their intake of tea and coffee due to an uncomfortable side effect ...

After that technology had proven its worth, the full-blown virtual hospital was launched by the Saudi ministry of health in ...

Verona Pharma will host an investment community webcast and conference call at 9:00 a.m. EST / 2:00 p.m. GMT on Thursday, ...

Feb. 14, 2025 — A study has found microscopic particles emitted from certain types of commonly ... in COPD patients. The researchers hope it will pave the way for new treatment ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Certain medications commonly used to treat asthma and COPD can damage the environment and worsen respiratory issues. KYW ...

Discover eight promising respiratory disease companies advancing their novel therapies through clinical trials in 2025.

GP trainer and palliative care lead Dr Nicolas Alexander advises on the key non-pain symptoms that patients experience during ...